Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure
Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The objective is to evaluate the efficacy and safety on the tolvaptan for increasing serum Na
levels in patients with worsening heart failure and hyponatremia.